Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
1.
Journal of Zhejiang University. Science. B ; (12): 280-290, 2020.
Article Dans Anglais | WPRIM | ID: wpr-1010534

Résumé

Tripterygium wilfordii Hook F has significant anti-inflammatory and immunosuppressive properties and is widely used for treating autoimmune and inflammatory diseases such as rheumatoid arthritis, systemic lupus erythematosus, and kidney disease, especially in traditional Chinese medicine. The mechanisms underlying its effects may be diverse but they remain unclear, and its toxicity and side effects limit its wider clinical application. This review summarizes the clinical application of Tripterygium wilfordii Hook F in recent years, as well as the results of studies into its mechanisms and toxicity, to provide a reference for its future clinical application.


Sujets)
Animaux , Humains , Anti-inflammatoires/pharmacologie , Polyarthrite rhumatoïde/traitement médicamenteux , Médicaments issus de plantes chinoises/usage thérapeutique , Immunosuppresseurs/pharmacologie , Inflammation/traitement médicamenteux , Maladies inflammatoires intestinales/traitement médicamenteux , Médecine traditionnelle chinoise , Pyroptose/effets des médicaments et des substances chimiques , Tripterygium
2.
Acta cir. bras ; 33(4): 375-385, Apr. 2018. tab, graf
Article Dans Anglais | LILACS | ID: biblio-886280

Résumé

Abstract Purpose: To investigate the effects of melatonin on antioxidant capacity, inflammation and apoptotic cell death (through expression of cleaved-caspase 3) in lung tissue samples of diabetic rats. Methods: Thirty male Sprague-Dawley rats were randomly divided into three groups. Group 1 (control group) was made up of healthy rats. Group 2 (diabetes group) received streptozotocin at a dose of 50 mg/kg/day for 5 days.Group 3 (diabetes plus melatonin group) received streptozotocin at a dose of 50 mg/kg/day for 5 days and then they received melatonin at a dose of 20 mg/kg/day between 28thand 35thdays of the study. Results: Tissue MDA and MPO levels were found to be significantly higher in diabetes group compared to control group (p<0.05) whilst administration of melatonin was found to significantly lower this increase down to normal levels (p<0.05). Bronchus associated lymphoid tissue (BALT) was more severe in diabetics whereas administration of melatonin alleviated this hyperplasia. Cleaved caspase 3 activity was severe in hyperplastic BALT in diabetic rats however in lowered down to moderate level when melatonin was administered. Conclusion: The melatonin caused an increase in antioxidant capacity and decreased the expression of cleaved-caspase 3.


Sujets)
Animaux , Mâle , Diabète expérimental/anatomopathologie , Caspase-3/analyse , Pyroptose/effets des médicaments et des substances chimiques , Poumon/effets des médicaments et des substances chimiques , Mélatonine/pharmacologie , Antioxydants/pharmacologie , Superoxide dismutase/analyse , Facteurs temps , Immunohistochimie , Peroxydation lipidique , Catalase/analyse , Répartition aléatoire , Reproductibilité des résultats , Rat Sprague-Dawley , Streptozocine , Myeloperoxidase/analyse , Diabète expérimental/complications , Diabète expérimental/métabolisme , Caspase-3/effets des médicaments et des substances chimiques , Glutathion/analyse , Poumon/métabolisme , Poumon/anatomopathologie , Malonaldéhyde/analyse
SÉLECTION CITATIONS
Détails de la recherche